newsfilter
← Latest News
GlobeNewswire·

Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020

- Company had $81 million of cash and cash equivalents as of December 31, 2020, and expects to receive additional $16 million in cash in 2021 from sale of Arvelle Therapeutics shares - Cash runway...